ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2022 American Transplant Congress

    Robotic-Assisted Reconstruction of the Transplant Ureter: A Minimally Invasive Option for a Rare Complication

    A. Popovic1, M. Hanlon2, S. Iskhagi2, R. Saidi2, S. Blakely3, R. Shahbazov2

    1Urology, Upstate Medical University, Syracuse, NY, 2Surgery, Division of Transplantation, SUNY, Upstate Medical University, Syracuse, NY, 3Urology, SUNY, Upstate Medical University, Syracuse, NY

    *Purpose: Ureteric stricture are rare after kidney transplants but nonetheless this complication requires reconstruction in the majority of cases to avoid graft dysfunction and/or failure.…
  • 2022 American Transplant Congress

    Lipid Metabolism Profile of Human Kidneys During Ex Vivo Normothermic Perfusion

    J. Yu, I. Palma, S. Adams, J. Sageshima, P. Than, R. Perez

    UC Davis Medical Center, Sacramento, CA

    *Purpose: The kidney is a highly metabolic organ and lipids are an important energy source. In this study, we examined the lipid profiles of discarded…
  • 2022 American Transplant Congress

    Dd-cfdna Correlates With Acute Rejection In The Setting Of Bk Viremia After Kidney Transplantation

    N. M. Ali1, J. Miles2, V. Tatapudi1, R. Chand1, R. Montgomery1

    1NYU Langone Transplant Institute, New York, NY, 2CareDx, Brooklyn, NY

    *Purpose: BK virus reactivation is common among kidney transplant recipients (KTRs) and is a risk factor for allograft loss. Currently, there is no clearly established…
  • 2022 American Transplant Congress

    Validation of the iBox Surrogate End Point in CNI Free, Belatacept Treated Patients (BENEFIT & BENEFIT-EXT)

    G. Divard1, O. Aubert1, M. Raynaud1, F. Vincenti2, L. Rostaing3, A. Durbach4, C. Legendre1, R. Vadanici5, A. Loupy1, -. BENEFIT & BENEFIT-EXT Investigators6

    1Paris Transplant Group, INSERM, Paris, France, 2UCSF, San Francisco, CA, 3Grenoble, Grenoble, France, 4APHP, Paris, France, 5BMS, Rueil Malmaison, France, 6BMS, New York, NY

    *Purpose: The iBox is a prognostication system for long-term kidney allograft survival, developed with mostly patients under a CNI based immunosuppression. Patients treated with a…
  • 2022 American Transplant Congress

    IL-15 Signaling is Required for the Maintenance of Tissue Resident Memory T Cells in Chronic Allograft Rejection

    R. Tieu1, Q. Zeng1, D. Zhao1, A. Williams1, J. Yun Tso2, F. Lakkis1, J. Yun Tso2

    1Starzl Transplantation Institute, Pittsburgh, PA, 2JN Biosciences, Mountain View, CA

    *Purpose: Currently, no immunotherapies have been clinically proven to prevent or treat chronic rejection. IL-15 is known to support memory T cell homeostasis. However, it…
  • 2022 American Transplant Congress

    Tacrolimus Exposure Estimation in Stable Kidney Transplant Recipients Using Maximum A Posteriori Bayesian Approach

    T. Nguyen1, N. M. Smith1, K. Attwood2, B. Murray3, K. Tornatore-Morse1

    1University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, 2School of Public Health; University at Buffalo, Buffalo, NY, 3Erie County Medical Center; School of Medicine/UB, Buffalo, NY

    *Purpose: Tacrolimus exhibits interpatient pharmacokinetic variability that impacts clinical responses and requires routine trough therapeutic drug monitoring. Tacrolimus troughs do not consistently predict area under…
  • 2022 American Transplant Congress

    Urinary Cell CTOT-04 Signature is Diagnostic of Glomerulitis in Kidney Allograft Biopsies

    T. Salinas1, C. Li1, C. Snopkowski1, K. Chen1, S. Albakry1, S. Salvatore2, S. Seshan2, J. R. Lee1, M. Thangamani1, D. Dadhania1, M. Suthanthiran1

    1Nephrology, Weill Cornell-NYPH, New York, NY, 2Pathology, Weill Cornell-NYPH, New York, NY

    *Purpose: Antibody mediated rejection is a significant complication after kidney transplantation and is an important cause of allograft failure. In the multicenter CTOT-04 study, we…
  • 2022 American Transplant Congress

    Treading the Paradigm Shift: A Single Center Comparative Study of Outcomes Between Pre-Emptive and Early Kidney Transplant with Non Pre-Emptive Kidney Transplant Recipients Innational Kidney and Transplant Institute

    E. U. Go, L. Baloloy

    Organ Transplantation and Vascular Surgery, National Kidney and Transplant Institute, Quezon City, Philippines

    *Purpose: To compare the 3-year outcome of pre-emptive and early kidney transplant recipients versus non pre-emptive recipients in our institution from January 2013 to December…
  • 2022 American Transplant Congress

    Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of T-cell Mediated Rejection in Kidney Transplant Biopsies

    D. Kumar1, I. Moinuddin1, L. Kamal1, M. Shinbashi1, N. Raju1, R. Minniti1, F. Moran1, P. Halloran2, G. Gupta1

    1Virginia Commonwealth University, Richmond, VA, 2University of Alberta, Edmonton, AB, Canada

    *Purpose: We have reported the correlation of donor-derived cell-free DNA (dd-cfDNA) with histologic and molecular diagnosis (MMDx) of kidney transplant biopsies (Gupta et al, Transplantation…
  • 2022 American Transplant Congress

    A More Equitable Transplant Evaluation: What Patient-Level Factors Impact Time to Kidney Transplant Evaluation Completion?

    T. Menser, M. J. Hobeika, E. Hsu, L. W. Moore, A. D. Waterman, A. O. Gaber, R. J. Knight

    Houston Methodist, Houston, TX

    *Purpose: The kidney transplant evaluation process can take months or years to complete depending on patient health status and level of engagement. This study examines…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences